Adherence to oral hypoglycemic agents in 26 782 chinese patients: A cohort study

Journal of Clinical Pharmacology

Volumn 51, Issue 10, 2011, Pages 1474-1482

  Wong, Martin C S ^a   Kong, Alice P S ^b   So, Wing Yee ^b   Jiang, Johnny Y ^c   Chan, Juliana C N ^b   Griffiths, Sian M ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b Department of Medicine and Therapeutics ^*  (Hong Kong)

^c PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

adherence; associated factors; Chinese; ethnicity; Oral hypoglycemic agents

Indexed keywords

BIGUANIDE DERIVATIVE; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CHINESE; COHORT ANALYSIS; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; RISK FACTOR;

EID: 80053288897     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270010382911     Document Type: Article

References (44)

1. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006 ; 29: 1263-1268 (Pubitemid 44125920)
2. Castell C, Tresserras R, Serra J, Goday A, Lloveras G, Salleras L. Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diabetes Res Clin Pract. 1999 ; 43: 33-40 (Pubitemid 29096409)
3. Lopatynski J, Mardarowicz G, Nicer T. The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland). Pol Arch Med Wewn. 2001 ; 106: 781-786
4. Shaw JE, Sicree R Contemporary Endocrinology: Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical Management. Feinglos MN Bethel MA, ed. Totowa, NJ: Humana Press ; 2008: 1-16.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 ; 27: 1047-1053 (Pubitemid 38579764)
6. Adler AI, Stratton IM, Neil HA. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000 ; 321: 412-419 (Pubitemid 30609443)
7. Simmons D, Williams DR, Powell MJ. The Coventry Diabetes Study: prevalence of diabetes and impaired glucose tolerance in Europids and Asians. Q J Med. 1991 ; 81: 1021-1030
8. Chan JCN, Ng MCY, Critchley JA, Lee SC, Cockram CS. Diabetes mellitus-a special medical challenge from a Chinese perspective. Diabetes Res Clin Pract. 2001 ; 54: S19-S27
9. McClean MT, McElnay JC, Andrews J. The importance of patient education and patient involvement in the treatment of diabetes. Pharm J. 2000 ; 265: 108-110
10. Filion KB, Joseph L, Boivin JF, Suissa S, Brophy JM. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf. 2009 ; 18: 973-976
11. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson HG. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy. 2002 ; 22: 1294-300 (Pubitemid 35155082)
12. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005 ; 118 (suppl 5A). 27S-34S (Pubitemid 40585813)
13. Cramer JA. A systematic review adherence with medications for diabetes. Diabetes Care. 2004 ; 27: 1218-1224 (Pubitemid 38579798)
14. Li W-W, Stewart AL, Stotts N, Froelicher ES. Cultural factors of Chinese immigrants as predictors of hypertensive medication compliance. Circulation. 2004 ; 110: III-393
15. Wong MCS, Jiang Y, Griffiths S. Switching of antihypertensive drugs among 93,286 Chinese patients: a cohort study. J Hum Hypertens. 2010 ;:
16. Wong MCS, Jiang Y, Griffiths S. Adherence to combination therapy among ethnic Chinese patients: a cohort study. Hypertens Res. 2010 ;:
17. Wong MCS, Jiang Y, Griffiths S. Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients. Am J Hypertens. 2009 ; 22: 904-910
18. Wong MCS, Jiang JY, Gibbs T, Griffiths S. Factors associated with antihypertensive drug discontinuation among Chinese patients: a cohort study. Am J Hypertens. 2009 ; 22: 802-810
19. Wong MCS, Jiang Y, Griffiths S. Short-term adherence to β-blocker therapy among ethnic Chinese patients with hypertension: a cohort study. Clin Ther. 2009 ; 31: 2170-2177
20. Wong MCS, Jiang Y, Griffiths S. Antihypertensive drug adherence among 6,408 Chinese patients on angiotensin converting enzyme inhibitors in Hong Kong: a cohort study. J Clin Pharmacol. 2009 ;:
21. Wong MCS, Jiang Y, Griffiths S. Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study. J Epidemiol Comm Health. :
22. Wong MCS, Jiang JY, Lam AT, Fung H, Griffiths S, Mercer SW. Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions. J Hum Hypertens. 2008 ; 22: 714-716
23. Yang Y, Thumula V, Pace PF, et al. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Clin Ther. 2009 ; 31: 2178-2188
24. Kalyango JN, Owino E, Nambuya AP. Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. Afr Health Sci. 2008 ; 8: 67-73
25. Chang HY, Chiou CJ, Lin MC, et al. A population study of the self-care behaviors and their associated factors of diabetes in Taiwan: results from the 2001 National Health Interview Survey in Taiwan. Prev Med. 2005 ; 40: 344-348
26. Wong MCS, Jiang JY, Tang JL, Lam AT, Fung H, Mercer SW. Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Serv Res. 2008 ; 8: 138
27. HA and clinical research-support, output and direction. http://www.ha.org.hk/ho/research-ethics/msdc-p181.pdf. Accessed January 9, 2010.
28. Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006 ; 47: 1039-1048 (Pubitemid 44289157)
29. Briesacher BA, Andrade SE, Fouayzi HH, Chan KA. Medication adherence and use of generic drug therapies. Am J Manag Care. 2009 ; 15: 450-456
30. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009 ; 25: 2303-2310
31. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002 ; 25: 1015-1021 (Pubitemid 41110487)
32. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997 ; 20: 1512-1517 (Pubitemid 27415025)
33. Boccuzzi SJ, Wogen J, Fox J, Sung JCY, Shah A, Kim J. Utilization of oral hypoglycemic agents in a drug-insured U.S. population. Diabetes Care. 2001 ; 24: 1411-1415 (Pubitemid 33716429)
34. Dailey G, Kim MS, Lian JF. Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a Medicaid population with type 2 diabetes mellitus. Clin Ther. 2001 ; 23: 1311-1320 (Pubitemid 32804123)
35. Melikian C, White TJ, Vanderplas A, Dezeii CM, Chang E. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther. 2002 ; 24: 460-467 (Pubitemid 34275867)
36. Dezii CM, Kawabata H, Tran M. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J. 2002 ; 95: 68-71 (Pubitemid 34131538)
37. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med. 2002 ; 19: 279-284 (Pubitemid 34592152)
38. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: The treatments people forgo, how often, and who is at risk. Am J Public Health. 2004 ; 94: 1782-1787 (Pubitemid 39331770)
39. Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA. 2002 ; 288: 475-482 (Pubitemid 34787479)
40. Piette JD, Schillinger D, Potter MB, Heisler M. Dimensions of patient-provider communication and diabetes self-care in an ethnically diverse population. J Gen Intern Med. 2003 ; 18: 624-633 (Pubitemid 37047035)
41. Mohamed IN, Helms PJ, Simpson CR, et al. Using routinely collected prescribing data to determine drug persistence for the purpose of pharmacovigilance. J Clin Pharmacol. 2010 ;:
42. Matsuyama JR, Mason BJ, Jue SG. Pharmacists' interventions using electronic medication-event monitoring device's adherence data versus pill counts. Ann Pharmacother. 1993 ; 27: 851-855 (Pubitemid 23225667)
43. Piette JD, Weinberger M, McPhee SJ, Crapo LA, Kraemer FB. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes?. Am J Med. 2000 ; 108: 20-27 (Pubitemid 30058274)
44. Krass I, Taylor SJ, Smith C, Armour CL. Pharmacists leading the way in diabetes care-the impact on medication use and adherence. JAPhA. 2005 ; 45: 35-40